82 FR 13123 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 45 (March 9, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 45 (March 9, 2017)
| Page Range | 13123-13123 | |
| FR Document | 2017-04626 |
[Federal Register Volume 82, Number 45 (Thursday, March 9, 2017)] [Notices] [Page 13123] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-04626] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to RFA-OH17-1701, Cooperative Agreement on Global Occupational Health with the World Health Organization (WHO). TIME AND DATE: 1:00 p.m.-5:00 p.m., EDT, April 11, 2017 (Closed). PLACE: Teleconference. STATUS: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. MATTERS FOR DISCUSSION: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``Cooperative Agreement on Global Occupational Health with the World Health Organization (WHO)'', RFA-OH17-1701. CONTACT PERSON FOR MORE INFORMATION: Nina Turner, Ph.D., Scientific Review Officer, NIOSH, CDC, 1095 Willowdale Road, Mailstop G905, Morgantown, West Virginia 26506, Telephone: (304) 285-5976. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017-04626 Filed 3-8-17; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 82, No. 45 / Thursday, March 9, 2017 / Notices 13123
and insufficient levels of evidence to the documents or comments received, go to TIME AND DATE: 1:00 p.m.–5:00 p.m.,
following: www.regulations.gov. For access to the EDT, April 11, 2017 (Closed).
‘‘Data sets classified as sufficient are original docket [NIOSH–153] to view PLACE: Teleconference.
those that include human and/or animal background documents or comments STATUS: The meeting will be closed to
studies conducted using standardized received, go to https://www.cdc.gov/ the public in accordance with
protocols and that provide complete niosh/docket/archive/docket153.html. provisions set forth in Section 552b(c)
descriptions of the exposure conditions All information received in response to (4) and (6), Title 5 U.S.C., and the
and study findings. Data sets classified this notice will be available for public Determination of the Director,
as limited are those that include human examination and copying at the NIOSH Management Analysis and Services
and/or animal studies conducted using Docket Office, 1150 Tusculum Avenue, Office, CDC, pursuant to Public Law 92–
non-standardized protocols or that Room 155, Cincinnati, OH 45226–1998. 463.
provide incomplete descriptions of the
FOR FURTHER INFORMATION CONTACT: MATTERS FOR DISCUSSION: The meeting
exposure conditions or study findings.
Naomi Hudson or G. Scott Dotson, will include the initial review,
Data sets classified as insufficient are
NIOSH, Education and Information discussion, and evaluation of
those that include human and/or animal
Division, Robert A. Taft Laboratories, applications received in response to
studies conducted using non-
1190 Tusculum Ave, MS C–32, ‘‘Cooperative Agreement on Global
standardized protocols and that provide
Cincinnati, OH 45226, email: iuz8@ Occupational Health with the World
incomplete descriptions of the exposure
cdc.gov or fya8@cdc.gov. Health Organization (WHO)’’, RFA–
conditions and study findings. Data sets
OH17–1701.
that receive the insufficient ranking will SUPPLEMENTARY INFORMATION: In 2009,
not be used as the basis for the NIOSH NIOSH published Current Intelligence CONTACT PERSON FOR MORE INFORMATION:
skin notation.’’ Bulletin 61—A Strategy for assigning Nina Turner, Ph.D., Scientific Review
Evaluation of dose-related effects in New NIOSH Skin Notations [NIOSH Officer, NIOSH, CDC, 1095 Willowdale
studies with limited or insufficient 2009–147; http://www.cdc.gov/niosh/ Road, Mailstop G905, Morgantown,
evidence, mechanistic data, and docs/2009-147/pdfs/2009-147.pdf]. The West Virginia 26506, Telephone: (304)
analogous chemical properties may be CIB presents a strategic framework that 285–5976.
factored into the classification scheme is a form of hazard identification that The Director, Management Analysis
for determining the level of evidence for ensures that the assigned skin notations and Services Office, has been delegated
identified studies. Data sets that provide reflect the contemporary state of the authority to sign Federal Register
insufficient evidence will not be used as scientific knowledge, provides notices pertaining to announcements of
the basis for the NIOSH skin notation transparency behind the assignment meetings and other committee
but, in some cases, may provide process, communicates the hazards of management activities, for both the
information to support or contradict chemical exposures of the skin, and Centers for Disease Control and
evidence for the skin notation. meets the needs of health professionals, Prevention and the Agency for Toxic
For data sets with conflicting employers, and others interested in Substances and Disease Registry.
findings, an overall determination based protecting workers from chemical Elaine L. Baker,
on the body of evidence will be contact with the skin. Published Skin Director, Management Analysis and Services
developed by evaluating data adequacy, Notation Profile documents are Office, Centers for Disease Control and
reliability and relevance, and assessing available at https://www.cdc.gov/niosh/ Prevention.
each study’s quality of evidence. The topics/skin/skin-notation_profiles.html. [FR Doc. 2017–04626 Filed 3–8–17; 8:45 am]
studies with the best quality and BILLING CODE 4163–18–P
validity to support the notation are Frank Hearl,
identified and cited in the individual Chief of Staff, National Institute for
Skin Notation Profile documents. Occupational Safety and Health, Centers for
Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
NIOSH seeks comments on proposed HUMAN SERVICES
changes as described above. [FR Doc. 2017–04628 Filed 3–8–17; 8:45 am]
DATES: Comments must be submitted on BILLING CODE 4163–18–P Centers for Disease Control and
or before April 10, 2017. Prevention
ADDRESSES: You may submit comments, DEPARTMENT OF HEALTH AND Advisory Committee to the Director
identified by CDC–2017–0017 and HUMAN SERVICES (ACD), Centers for Disease Control and
docket number NIOSH 153–D, by any of Prevention (CDC)
the following methods: Centers for Disease Control and
• Federal eRulemaking Portal: http:// Prevention In accordance with section 10(a)(2) of
www.regulations.gov. Follow the the Federal Advisory Committee Act
instructions for submitting comments. Disease, Disability, and Injury (Pub. L. 92–463), the Centers for Disease
• Mail: National Institute for Prevention and Control Special Control and Prevention (CDC)
Occupational Safety and Health, NIOSH Emphasis Panel (SEP): Initial Review announces the following meeting of the
Docket Office, 1090 Tusculum Avenue, aforementioned committee:
MS C–34, Cincinnati, Ohio 45226–1998. In accordance with Section 10(a)(2) of Time and Date: 8:30 a.m.–3:00 p.m.,
Instructions: All information received the Federal Advisory Committee Act EDT, April 20, 2017.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
in response to this notice must include (Pub. L. 92–463), the Centers for Disease Place: CDC, Building 19, Auditorium
the agency name and docket number Control and Prevention (CDC) B3, 1600 Clifton Road NE., Atlanta,
[CDC–2017–0017; NIOSH 153–D]. All announces a meeting for the initial Georgia 30329.
relevant comments received will be review of applications in response to Status: Open to the public, limited
posted without change to RFA–OH17–1701, Cooperative only by the seating and phone lines
www.regulations.gov, including any Agreement on Global Occupational available. The meeting room
personal information provided. For Health with the World Health accommodates approximately 60
access to the docket to read background Organization (WHO). people. Advance registration for in-
VerDate Sep<11>2014 17:43 Mar 08, 2017 Jkt 241001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM 09MRN1](https://thefederalregister.org/doc/82_FR_13168/page/1.svg)
Document Created: 2017-03-09 04:58:19
Document Modified: 2017-03-09 04:58:19
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | 1:00 p.m.-5:00 p.m., EDT, April 11, 2017 (Closed). | |
| FR Citation | 82 FR 13123 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR